ARCA Hero Image
Evaluated rNAPc2 as a potential treatment for severe COVID-19
ASPEN-COVID-19
Phase 2b Clinical Trial
Evaluated rNAPc2 as a potential treatment for severe COVID-19
ASPEN-COVID-19
Phase 2b Clinical Trial
hex-clinical-trial

Status

ASPEN-COVID-19 topline results reported March 2022

U.S. FDA Fast Track designation granted Nov 2020